Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-2-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1026-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8932864-Adult,
pubmed-meshheading:8932864-Female,
pubmed-meshheading:8932864-Hepatic Veno-Occlusive Disease,
pubmed-meshheading:8932864-Humans,
pubmed-meshheading:8932864-Recombinant Proteins,
pubmed-meshheading:8932864-Tissue Plasminogen Activator,
pubmed-meshheading:8932864-Treatment Outcome
|
pubmed:year |
1996
|
pubmed:articleTitle |
High-dose, continuous r-TPA infusion for treatment of VOD.
|
pubmed:publicationType |
Letter,
Case Reports
|